Natural Health Science Foundation Assessment Further Verifies Tilray Medical’s High-Quality Standard and its CBD100 Product for Clinical Trial Use
SYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has received approval and verification from The Natural Health Science Foundation (“NHSF”) of its flagship product, Tilray Purified Oral Solution (“OS”) CBD100, to be used in clinical trials in Australia and New Zealand.
Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, “The NHSF (Natural Health Science Foundation) Quality and Equivalency test approval is a testament to the high standards Tilray Medical upholds across all international cannabis markets. As Tilray continues to grow, we are extremely proud to be recognized as a trusted cannabis partner and for the quality standards we deliver for patients worldwide.”
George Polimenakos, General Manager, Tilray Medical ANZ (Australia and New Zealand) noted, “We are extremely pleased with this outcome and proud to provide EU-GMP certified products to patients in Australia and New Zealand. Having our product quality validated by the NHSF demonstrates Tilray’s commitment to delivering the highest quality cannabis products to our patients.”
The NHSF is an independent not-for-profit organization that assists patients, consumers, and healthcare professionals in making informed natural medicine choices based on robust science. NHSF believes natural medicines will be valuable in modern scientific medical practice if they follow best practices of quality, safety, and efficacy through transparency and evidence.
Nigel Pollard, Chairman, Natural Health Science Foundation, said, “Tilray Purified OS CBD100 has been thoroughly assessed by independent experts and has met the Quality & Equivalence standards of the Natural Health Science Foundation. This means the product has a basis of reproducibility which serves as a valid medical intervention, from a scientific point of view, for patient use and to test in a clinical trial.”
In addition to the approval received from the NHSF standard of scientific reproducibility for clinical trials, the New Zealand Ministry of Health has verified that the Tilray Purified OS CBD100 has met its quality standards to ensure consistency of the products that medical practitioners prescribe to their patients.
Tilray Medical is one of the leading providers of medical cannabis in Australia and New Zealand for commercial, compassionate access, and research purposes. Patients in Australia and New Zealand may seek access to medical cannabis products by consulting their healthcare practitioner.
About Tilray Medical
Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.
For more information about Tilray Medical in Australia and New Zealand, visit: https://www.tilray.com.au/
For more information about Tilray’s medicinal cannabis workshops in Australia, visit: https://tilray.medihuanna.com/
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and providing access to products that meet the needs of their mind, body, and soul while invoking wellbeing. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we open a world of well-being, visit www.tilray.com and follow @tilray on all social platforms.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things: expectations regarding the performance and scale of the Company, including Tilray Medical; and the Company’s ability to expand its offering to patients worldwide, including via Tilray Medical. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
For further information:
Media
Berrin Noorata
Tilray Global: news@tilray.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
Related Quotes
CVS Health Corp on Monday agreed to buy home healthcare services company Signify Health for about $8 billion in cash, a move that will enable one of the largest U.S. healthcare companies to provide further care management to patients in their homes. Healthcare companies like CVS have been expanding beyond managing health and pharmacy benefits with acquisitions of doctors groups and surgical centers in recent years. "We’ve been very clear about what we were looking for in expanding our health services, either be it primary care, provider enablement or in the home, and Signify Health clearly checks off two boxes: into the home and provider enablement," CVS CEO Karen Lynch said in an interview.
Novavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in Switzerland for adolescents aged 12 to 17 and as a booster in adults aged 18 years and above.
Following FDA approval for label expansion, Vertex Pharmaceuticals' (VRTX) Orkambi is now approved for treating cystic fibrosis in children aged one year and older.
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today. Most of the article was written a year ago and discuss what hedge funds thought about those companies at that time. The biggest loser in the list is probably Moderna (MRNA) which […]
Ischemic stroke occurs when a blood clot blocks the flow of blood through a narrow artery to the brain. This triggers a major medical emergency as the brain quickly becomes deprived of necessary oxygen and nutrients. While there are many factors which can contribute to your stroke risk, researchers have recently found that one somewhat unexpected factor—your blood type—could make you 16 percent more likely to experience a stroke before the age of 60. Read on to learn whether you're at heightened
The liver is a three pound organ that performs over 500 vital jobs for us daily without a break, so taking care of the liver is essential for overall health. The liver performs important duties like discarding waste, maintaining blood sugar levels, regulating blood clotting and more. You can't live without your liver so when it's in trouble, so are you. Eat This, Not That! Health spoke with experts who share seven ways you're damaging your liver that you might not realize. Read on—and to ensure
KUALA LUMPUR (Reuters) -Former Malaysian Prime Minister Mahathir Mohamad was discharged from hospital on Sunday after being admitted for COVID-19, his office said in a statement. Mahathir, admitted to the National Heart Institute on Wednesday after testing positive for the coronavirus, will remain quarantined at home until Tuesday, the statement said. He has received at least three doses of COVID vaccine, the last known shot in November 2021, according to earlier comments from him and government officials.
The brain is undeniably the most important and powerful organ in our body, but also highly vulnerable to injury and disease. A blood clot in your brain is a serious health condition, "that can lead to stroke or even death," Dr. Tomi Mitchell, a Board-Certified Family Physician with Holistic Wellness Strategies tells us. "While prompt medical treatment is essential, it can be challenging to identify the symptoms of a brain clot. However, four key signs may indicate that you have a clot in your br
The Ministry of Health of Ukraine plans to allow all citizens to receive a second booster vaccination against COVID-19 in September, chief sanitary doctor Ihor Kuzin said in an interview with Ukrinform news agency published on Sept. 4.
Springfield's suicide mortality rate is 60% worse than the national average, according to the 2020 Ozarks Health Commission report.
As a new study confirms drinking too much really does make you look older, Lisa Salmon looks into other lifestyle factors that may contribute too
‘If I can save just one other life by being open about my battle then it’s worth speaking out’
Masimo's (MASI) full-market consumer release of the Masimo W1 and other related launches is likely to significantly improve RPM.
Cansino Biologics' inhaled vaccine appeared more effective in clinical trials than China's other jabs.
The vegetable was shown to lower blood sugar levels and cholesterol levels
Abortion looms large in Florida elections Nov. 8 | Bill Cotterell
Trying to work 24/7 takes a toll on health and productivity. Workers need to know when to get off the clock.
If you experience inflammation in your joints that causes pain and stiffness, you may be one of the 58.5 million people in the United States who suffer from arthritis. Arthritis can worsen with age, and there is no cure for it. However, there are ways to help relieve some of the symptoms or help slow it down. These include lifestyle changes, which can start with being mindful about the foods you eat.Certain foods have been shown to alleviate some of the discomfort and pain associated with arthri
Officials now working to identify the source of the outbreak, which has left four people dead
States around the country are making it easier for new moms to keep Medicaid in the year after childbirth, a time when depression and other health problems can develop. “A lot of things have changed since the pandemic,” said Venessa Aiken, a new mom in Orlando, Florida. “A lot of places no longer take Medicaid or if they do, you have to wait like two months before you can be seen.”
